Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GlobalData
Marketing
Arrowhead's plozasiran could reach $700M-plus in sales: report
The drug has shown promise in reducing triglycerides and the protein APOC3, meaning it could be used to treat many forms of dyslipidemia.
Andrea Park
Apr 16, 2024 3:05pm
Generics face 'knowledge gap' against brand loyalty: GlobalData
Apr 8, 2024 12:09pm
Governments need to boost CRC awareness among younger adults
Mar 21, 2024 9:24am
Analysts tip label expansion to bolster GSK's hand in RSV fight
Feb 7, 2024 7:20am
Gene therapies on the cusp to ‘disrupt’ Gaucher disease market
Nov 30, 2023 9:37am
Amgen, Regeneron join Lilly and Novo with Q3 market-cap gains
Oct 30, 2023 11:00am